Research Article, J Otol Rhinol Vol: 3 Issue: 5
Acellular Human Dermal Allograft in Canal Wall Down Mastoidectomy and Considerations of Graft Thickness
Dennis C. Fitzgerald1, Andrew J. Steehler2*, Matthew K.Steehler1,3 and Benjamin J. Wycherly4 | |
1Washington Hospital Center, Department of Otolaryngology - Head and Neck Surgery, Washington, DC, USA | |
2University of Pittsburgh, Department of Biological Sciences, Pittsburgh, PA, USA | |
3Ear, Nose, and Throat Associates of Corpus Christi, Department of Otolaryngology - Head and Neck Surgery, Corpus Christi, TX, USA | |
4The Connecticut Sinus and Otology Institute, Farmington, CT, USA | |
Corresponding author : Andrew J. Steehler 402 Wilkins Road, Erie, PA 16505, USA Tel: (814)882-0373 E-mail: ajs248@pitt.edu |
|
Received: February 14, 2014 Accepted: June 15, 2014 Published: July 01, 2014 | |
Citation: Fitzgerald DC, Steehler AJ, Steehler MK, Wycherly BJ (2014) Acellular Human Dermal Allograft in Canal Wall Down Mastoidectomy and Considerations of Graft Thickness. J Otol Rhinol 3:4. doi:10.4172/2324-8785.1000162 |
Abstract
Acellular Human Dermal Allograft in Canal Wall Down Mastoidectomy and Considerations of Graft Thickness
Objectives/Hypothesis: Describe our method and results to observe the optimal thickness of AlloDerm used in canal-wall-down mastoidectomy defects.
Study Design: Retrospective consecutive case series.
Methods: AlloDerm with an average thickness of 0.33 to 0.76 mm was used; selecting the portions of tissue with a thickness closest to 0.5 mm to line mastoid cavity defects. Failures occurred when AlloDerm’s thickness was beyond the average of 0.76mm. We report time to healing as well as long term results including need for revision surgery and skin breakdown.